Fuji Pharma Co (FRA:FUP) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 26, 2026)


FRA:FUP Fuji Pharma Co Ltd FRA:FUP
84 GF Score
Price €11.60
GF Value €9.61
! 5 Warning Signs
View Full Analysis

What is Fuji Pharma Co Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Fuji Pharma Co's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

FRA:FUP vs ZTS: Margin of Safety % (DCF FCF Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Fuji Pharma Co's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fuji Pharma Co Margin of Safety % (DCF FCF Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fuji Pharma Co's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Fuji Pharma Co's Margin of Safety % (DCF FCF Based) falls into.


FRA:FUP
84GF Score
Fuji Pharma Co Ltd FRA:FUP
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fuji Pharma Co (FRA:FUP) Overvalued in 2026?

Based on GuruFocus' analysis, Fuji Pharma Co stock appears to be overvalued. The current stock price of €11.60 is trading 20.7% above its estimated GF Value™ of €9.61.

Key valuation signals for FRA:FUP:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: €9.61 vs. price of €11.60 (20.7% above fair value)
  • GF Score™: 84/100 with 5 warning signs

No single metric tells the full story. See the FRA:FUP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fuji Pharma Co Business Description

Other Exchanges 4554:Japan
Address 5-7 Sanban-cho, Chiyoda-ku, Tokyo, JPN, 102-0075
Fuji Pharma Co Ltd is involved in the development, manufacture, and marketing of pharmaceutical products, such as injection agents, internal drugs, drugs for external use, and diagnostic products. The group consists of a single segment, the pharmaceutical business.
84GF Score

Get the complete analysis for FRA:FUP

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.60
Price
€9.61
GF Value